Double BCG vaccination in a neonate: implications, management and prevention

dc.contributor.authorChinmay Chetan
dc.contributor.authorSaikat Patra
dc.contributor.authorShailendra Kumar Singh
dc.contributor.authorGirish Gupta
dc.date.accessioned2025-09-27T05:01:09Z
dc.date.issued2023-12-01
dc.description.abstractTuberculosis is a common cause of morbidity and mortality especially in low-income and middle-income countries like India. BCG vaccination is recommended for all neonates after birth in areas with a high tuberculosis disease burden. Here, we describe a case where a neonate received two doses of the BCG (Chennai strain) vaccine within a span of 4 days after birth due to a vaccination error. Parents were informed about the event. The infant was managed conservatively and followed up till 12 months of life for any possible complication. There were no serious adverse effects apart from the localised reaction and a double scar on the left arm. Measures to avoid any such error in the future and the need for reporting medication error has been highlighted. Parental concerns are frequent in such scenarios and should be actively addressed.
dc.identifier.citationChetan C, Patra S, Singh SK, Gupta G. Double BCG vaccination in a neonate: implications, management and prevention. BMJ Case Rep. 2023 Dec 28;16(12):e256766. doi: 10.1136/bcr-2023-256766. PMID: 38154875; PMCID: PMC10759019.
dc.identifier.issn1757-790X
dc.identifier.urihttp://10.0.2.71:4000/handle/123456789/274
dc.language.isoen
dc.publisherPUBMED
dc.subjectNeonatal health
dc.subjectPaediatrics (drugs and medicines)
dc.subjectTB and other respiratory infections
dc.subjectVaccination/immunisation
dc.titleDouble BCG vaccination in a neonate: implications, management and prevention
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Double BCG vaccination in a.pdf
Size:
115.36 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: